Item 8.01 Other Events.

Warner Chilcott plc (together with its subsidiaries, the "Company") today announced that Bayer Pharma AG (together with its affiliates, "Bayer") filed a complaint against the Company in the United States District Court for the District of Delaware alleging that the Company's manufacture, use, offer for sale, and/or sale of its Lo Loestrin ® FE oral contraceptive product infringes Bayer's U.S. Patent No. 5,980,940. In the complaint, Bayer seeks injunctive relief and unspecified monetary damages. The Company believes the complaint lacks merit and that it has a number of strong defenses to the allegations in the complaint and intends to vigorously defend the litigation.

---